The Pattern of Mobile Phone Use and Prevalence of Self-Reported Symptoms in Elementary and Junior High School Students in Shiraz, Iran

od Mortazavi, Seyed Mohammad Javad, Atefi, Mohammad, Kholghi, Fatemeh
Izdano 2011

Scientific Publications on Medical Ethics in Thomson Reuters Database, 1990-2010

od Morovati, Marzieh, Ejraei, Akbar, Hadi, Zohre, Atefi, Mohammad, Morovati, Mohammad Javad
Izdano 2012

Lactate, a Neglected Factor for Diabetes and Cancer Interaction

od Wu, Yong, Dong, Yunzhou, Atefi, Mohammad, Liu, Yanjun, Elshimali, Yahya, Vadgama, Jaydutt V.
Izdano u Mediators Inflamm (2016)

Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma

od Lassen, Amanda, Atefi, Mohammad, Robert, Lidia, Wong, Deborah JL, Cerniglia, Michael, Comin-Anduix, Begonya, Ribas, Antoni
Izdano 2014

Proinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells

od Chung, Seyung S., Wu, Yong, Okobi, Quincy, Adekoya, Debbie, Atefi, Mohammad, Clarke, Orette, Dutta, Pranabananda, Vadgama, Jaydutt V.
Izdano u Mediators Inflamm (2017)

CRAF R391W is a melanoma driver oncogene

od Atefi, Mohammad, Titz, Bjoern, Tsoi, Jennifer, Avramis, Earl, Le, Allison, Ng, Charles, Lomova, Anastasia, Lassen, Amanda, Friedman, Michael, Chmielowski, Bartosz, Ribas, Antoni, Graeber, Thomas G.
Izdano u Sci Rep (2016)

Aberrant phosphorylation of SMAD4 Thr277-mediated USP9x-SMAD4 interaction by free fatty acids promotes breast cancer metastasis

od Wu, Yong, Yu, Xiaoting, Yi, Xianghua, Wu, Ke, Dwabe, Sami, Atefi, Mohammad, Elshimali, Yahya, Kemp, Kevin T., Bhat, Kruttika, Haro, Jesse, Sarkissyan, Marianna, Vadgama, Jaydutt V
Izdano u Cancer Res (2017)

Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma

od Atefi, Mohammad, Avramis, Earl, Lassen, Amanda, Wong, Deborah, Robert, Lidia, Foulad, David, Cerniglia, Michael, Titz, Bjoern, Chodon, Thinle, Graeber, Thomas G., Comin-Anduix, Begonya, Ribas, Antoni
Izdano 2014

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

od Finn, Richard S, Dering, Judy, Conklin, Dylan, Kalous, Ondrej, Cohen, David J, Desai, Amrita J, Ginther, Charles, Atefi, Mohammad, Chen, Isan, Fowst, Camilla, Los, Gerret, Slamon, Dennis J
Izdano 2009

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma

od Atefi, Mohammad, Titz, Bjoern, Avramis, Earl, Ng, Charles, Wong, Deborah JL, Lassen, Amanda, Cerniglia, Michael, Escuin-Ordinas, Helena, Foulad, David, Comin-Anduix, Begonya, Graeber, Thomas G, Ribas, Antoni
Izdano u Mol Cancer (2015)

Reversing Melanoma Cross-Resistance to BRAF and MEK Inhibitors by Co-Targeting the AKT/mTOR Pathway

od Atefi, Mohammad, von Euw, Erika, Attar, Narsis, Ng, Charles, Chu, Connie, Guo, Deliang, Nazarian, Ramin, Chmielowski, Bartosz, Glaspy, John A., Comin-Anduix, Begonya, Mischel, Paul S., Lo, Roger S., Ribas, Antoni
Izdano 2011

Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function

od Wong, Deborah J.L., Rao, Amol, Avramis, Earl, Matsunaga, Douglas R., Komatsubara, Kimberly M., Atefi, Mohammad S., Escuin-Ordinas, Helena, Chodon, Thinle, Koya, Richard C., Ribas, Antoni, Comin-Anduix, Begoña
Izdano 2014

PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody

od Escuin-Ordinas, Helena, Elliott, Mark W, Atefi, Mohammad, Lee, Michelle, Ng, Charles, Wei, Liu, Comin-Anduix, Begoña, Montecino-Rodriguez, Encarnacion, Avramis, Earl, Radu, Caius, Sharp, Leslie L, Ribas, Antoni
Izdano 2013

Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

od Wong, Deborah JL, Robert, Lidia, Atefi, Mohammad S, Lassen, Amanda, Avarappatt, Geetha, Cerniglia, Michael, Avramis, Earl, Tsoi, Jennifer, Foulad, David, Graeber, Thomas G, Comin-Anduix, Begonya, Samatar, Ahmed, Lo, Roger S, Ribas, Antoni
Izdano 2014

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma

od Wong, Deborah JL, Robert, Lidia, Atefi, Mohammad S, Lassen, Amanda, Avarappatt, Geetha, Cerniglia, Michael, Avramis, Earl, Tsoi, Jennifer, Foulad, David, Graeber, Thomas G, Comin-Anduix, Begonya, Samatar, Ahmed, Lo, Roger S, Ribas, Antoni
Izdano u Mol Cancer (2015)

Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress

od Tsoi, Jennifer, Robert, Lidia, Paraiso, Kim, Galvan, Carlos, Sheu, Katherine M., Lay, Johnson, Wong, Deborah J.L., Atefi, Mohammad, Shirazi, Roksana, Wang, Xiaoyan, Braas, Daniel, Grasso, Catherine S., Palaskas, Nicolaos, Ribas, Antoni, Graeber, Thomas G.
Izdano u Cancer Cell (2018)

COX‐2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors

od Escuin-Ordinas, Helena, Atefi, Mohammad, Fu, Yong, Cass, Ashley, Ng, Charles, Huang, Rong Rong, Yashar, Sharona, Comin-Anduix, Begonya, Avramis, Earl, Cochran, Alistair J., Marais, Richard, Lo, Roger S., Graeber, Thomas G., Herschman, Harvey R., Ribas, Antoni
Izdano 2013

JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma

od Titz, Bjoern, Lomova, Anastasia, Le, Allison, Hugo, Willy, Kong, Xiangju, ten Hoeve, Johanna, Friedman, Michael, Shi, Hubing, Moriceau, Gatien, Song, Chunying, Hong, Aayoung, Atefi, Mohammad, Li, Richard, Komisopoulou, Evangelia, Ribas, Antoni, Lo, Roger S, Graeber, Thomas G
Izdano u Cell Discov (2016)

Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

od von Euw, Erika, Atefi, Mohammad, Attar, Narsis, Chu, Connie, Zachariah, Sybil, Burgess, Barry L, Mok, Stephen, Ng, Charles, Wong, Deborah JL, Chmielowski, Bartosz, Lichter, David I, Koya, Richard C, McCannel, Tara A, Izmailova, Elena, Ribas, Antoni
Izdano 2012

Dendritic Cell-Based Immunotherapy in Prevention and Treatment of Renal Cell Carcinoma: Efficacy, Safety, and Activity of Ad-GM∙CAIX in Immunocompetent Mouse Models

od Birkhäuser, Frédéric D, Koya, Richard C, Neufeld, Caleb, Rampersaud, Edward N, Lu, Xuyang, Micewicz, Ewa D, Chodon, Thinle, Atefi, Mohammad, Kroeger, Nils, Chandramouli, Gadisetti VR, Li, Gang, Said, Jonathan W, McBride, William H, Kabbinavar, Fairooz F, Ribas, Antoni, Pantuck, Allan J, Belldegrun, Arie S, Riss, Joseph
Izdano u J Immunother (2013)